Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed

On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.

Copyright 2020 NPR

Sydney Lupkin is the pharmaceuticals correspondent for NPR.